investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Connecting Single Cell Heterogeneity to Clinical Descriptors of Clonal Evolution in Acute Myeloid Leukemia
Amy Paguirigan
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Amy Paguirigan
Fred Hutchinson Cancer Research Center
Seattle, United States
Related projects
Michael L Cleary
Role of PGDH in leukemia pathogenesis
Leukaemia
John D Schuetz
Metabolic pathways in leukemia
Leukaemia
M. James You
CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF
Leukaemia
James You
Role of MicroRNAs in the Tumorigenesis of T-ALL
Leukaemia
Pathology
Hematology and hematologic malignancies
Charles G Mullighan
Functional analysis of leukemic CREBBP mutations
Leukaemia
Pediatric oncology or childhood cancer
David FitzGerald
Bio-Therapies for the Treatment of Cancer
Leukaemia
Anthony G Letai
Probing mitochondria and personalizing leukemia therapy with BH3 profiling
Leukaemia
Terry Fry
Adoptive T cell Therapy for Pediatric Leukemia
Leukaemia
Pediatric oncology or childhood cancer
Michael Kharas
Characterizing MSI2 in leukemia
Leukaemia